Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2020-08-06 | 2020-08-03 | B Purchase | Anand Chittajallu Director |
33,519
102.30
₹2,426,008 |
33,519 | 102.30 | ₹2,426,008 | |
| 2020-08-06 | 2020-08-03 | B Purchase | Umakanth Katta Director |
9,990
364.75
₹588,731 |
9,990 | 364.75 | ₹588,731 | |
| 2020-07-15 | 2020-07-13 | B Purchase | Umakanth Katta Director |
57,740
75.01
₹3,380,008 |
57,740 | 75.01 | ₹3,380,008 | |
| 2019-02-08 | 2019-02-06 | B Purchase | Vasant V Alli Large shareholder |
190,574
37.50
₹7,146,525 |
190,574 | 37.50 | ₹7,146,525 | |
| 2019-01-25 | 2019-01-24 | B Purchase | Vasant V Alli Large shareholder |
189,851
37.50
₹7,119,412 |
189,851 | 37.50 | ₹7,119,412 | |
| 2018-12-30 | 2018-12-26 | B Purchase | Vasant V Alli Revised Large shareholder |
837,720
37.48
₹31,400,000 |
837,720 | 37.48 | ₹31,400,000 | |
| 2017-08-01 | 2017-07-28 | B Purchase | Dhananjaya Alli Director Large shareholder |
511,561
24.05
₹12,303,043 |
511,561 | 24.05 | ₹12,303,043 | |
| 2017-08-01 | 2017-07-28 | B Purchase | Vista Pharmaceuticals Inc Large shareholder |
211,000
24.05
₹5,074,550 |
211,000 | 24.05 | ₹5,074,550 | |
| 2017-07-11 | 2017-07-07 | B Purchase | Dhananjaya Alli Revised Director Large shareholder |
768,439
24.05
₹18,480,958 |
768,439 | 24.05 | ₹18,480,958 | |
| 2017-07-11 | 2017-07-07 | B Purchase | Vista Pharmaceuticals Inc Revised Large shareholder |
356,192
24.05
₹8,566,418 |
356,192 | 24.05 | ₹8,566,418 | |
| 2017-04-17 | 2017-04-13 | B Purchase | Dhananjaya Alli Director Large shareholder |
150,000
24.05
₹3,607,500 |
150,000 | 24.05 | ₹3,607,500 | |
| 2017-04-17 | 2017-04-13 | B Purchase | Vista Pharmaceuticals Inc Large shareholder |
78,714
24.05
₹1,893,072 |
78,714 | 24.05 | ₹1,893,072 | |
| 2017-04-03 | 2017-03-31 | B Purchase | Vista Pharmaceuticals Inc Large shareholder |
1,571,286
24.05
₹37,789,428 |
1,571,286 | 24.05 | ₹37,789,428 |
More insider trading research around Vista Pharmaceuticals Ltd